|Bid||60.56 x 100|
|Ask||60.62 x 200|
|Day's Range||59.73 - 60.71|
|52 Week Range||37.34 - 68.07|
|PE Ratio (TTM)||77.39|
|Earnings Date||Nov 20, 2017 - Nov 24, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.18|
Short interest is low for VEEV with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold VEEV had net inflows of $770 million over the last one-month.
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Veeva Systems, Inc. a score of 91. Our analysis is based on comparing Veeva Systems, Inc. with the following peers – Castlight Health, Inc. Class B, DXC Technology Co., Model N, Inc., Nuance Communications, Inc., Microsoft Corporation, Computer Programs and Systems, Inc., HealthStream, Inc. and Cerner Corporation ... Read more (Read more...)
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Veeva Systems, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
Veeva Systems treaded above its 50-day moving average for the first time in two months after an analyst recommended the stock.
The cost-effectiveness of cloud-based applications over in-premise applications is attracting life science companies. Veeva's (VEEV) industry-specific focus lends it a significant leverage.
Align Biopharma™, a life sciences industry technology standards group, today published a final open technology standard for identity management. Members from leading pharmaceutical, technology, and service provider companies reviewed and defined the technical requirements for products to enable a single sign-on service for healthcare professionals .
Veeva Systems Inc. , a leading provider of industry cloud solutions for the global life sciences industry, will host its financial analyst and investor day in San Francisco on Wednesday, October 11, 2017.
Accenture (ACN) Collaborates with Veeva Systems. We remain positive on company's sustained focus on product roll outs, along with major acquisitions.
2017 Veeva Global R&D Summit — Veeva Systems today announced that Veeva Vault Development Cloud is gaining momentum as the technology foundation for drug development in life sciences.
Accenture today announced it is working with Veeva Systems , a leader in cloud-based software for the global life sciences industry, to bring Veeva Vault RIM – a transformative regulatory information management solution – to biopharma companies.
If you are looking to invest in Veeva Systems Inc’s (NYSE:VEEV), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...
Veeva Systems announced that Veeva Vault Quality is helping an increasing number of life sciences customers to modernize quality and content management in the cloud. The number of Vault Quality customers has increased to 120, including four of the top 20 largest biopharmaceutical companies and 30 Veeva Vault QMS customers.
2017 Veeva Global R&D Summit—Veeva Systems announced that Veeva Vault CTMS is gaining momentum with global biopharmaceutical companies and clinical research organizations.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Veeva Systems, Inc. Here are 5 ETFs with the largest exposure to VEEV-US. Comparing the performance and risk of Veeva Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Short interest is low for VEEV with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding VEEV totaled $766 million.
Today at Advamed’s 2017 MedTech Conference, Veeva Systems announced that Veeva Vault is helping a growing number of medical device and diagnostics companies improve quality and efficiency to meet new compliance standards.
Short interest is low for VEEV with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold VEEV had net inflows of $1.44 billion over the last one-month.